Aquuinnah Pharmaceuticals

American biotechnology company in Massachusetts working on small molecules for neurodegenerative disease. Targets the stress granule biology that underlies the abnormal accumulation of RNA binding proteins such as TDP-43 in amyotrophic lateral sclerosis and frontotemporal dementia, runs its own discovery chemistry and cell based screening, and works with academic founders and partners on preclinical development.